Countries at the top of the list, such as No. 1 Germany, are positioned with stronger, more competitive economies that use less energy to achieve the same or better results than other nations, according to the American Council for an Energy Efficient Economy, which released the scorecard last week.
Germany, like many industrial countries, has been relying on coal and nuclear power to produce most of its electricity. But not for much longer.
The country is in the middle of an ambitious overhaul of its power supply system called Energiewende. When it’s finished in 2050, renewable energy sources like wind, solar and hydro will deliver 60 percent of Germany’s power.
ST. LOUIS -- Nuclear medicine scanning will be enriched with the introduction of GE Healthcare's Discovery*^ NM/CT 670 Pro, announced today at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). The vision of quantitative accuracy in nuclear medicine is enabled by Q.Metrix^ and Q.AC^, GE Healthcare's newest software innovations in nuclear medicine.
business unit
tags
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
business unit
tags
HOUSTON---June 3, 2014---GE (NYSE: GE) today announced that it has successfully completed its acquisition of Cameron's Reciprocating Compression division for $550 million USD.
The division provides reciprocating compression equipment and aftermarket parts and services for oil and gas production, gas processing, gas distribution and independent power industries. Cameron's Reciprocating Compression division has approximately 900 employees and operates from 20 global locations.
business unit
tags
Next-generation OligoProcess system has potential to help pharmaceutical industry save time and money
CHALFONT ST. GILES, UK and FRANKFURT, GERMANY -- 13 May 2014 -- GE Healthcare Life Sciences (NYSE: GE) and German oligonucleotide manufacturer BioSpring GmbH announced today that BioSpring has selected and installed GE Healthcare Life Sciences' OligoProcess, a fully automated oligonucleotide synthesizer, as a core element of its state-of-the-art production facility in Frankfurt.